A new British Journal of Clinical Pharmacology study indicates that certain markers can help predict which patients may experience problems after receiving an organ transplant.

The urinary markers, called miR-155-5p and CXCL10, can be measured after transplantation to predict the likelihood of acute rejection and .

"Large prospective randomised multicentre trials are warranted to refine our cut-off values and validate the clinical usefulness of these biomarkers," wrote the authors of the study.

More information: British Journal of Clinical Pharmacology (2017). DOI: 10.1111/bcp.13399

Journal information: British Journal of Clinical Pharmacology

Provided by Wiley